PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

Market Cap	6.33B
Revenue (ttm)	1.77B
Net Income (ttm)	205.85M
Shares Out	198.89M
EPS (ttm)	1.03
PE Ratio	30.92
Forward PE	21.23
Dividend	0.31 (0.97%)
Ex-Dividend Date	Jun 14, 2024

Volume	8,828,112
Average Volume	6,530,018
Open	31.00
Previous Close	31.50
Day's Range	31.00 - 32.77
52-Week Range	24.38 - 45.80
Beta	0.77
RSI	44.16
Earnings Date	Apr 28, 2025

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,455
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300725

Financial Performance

In 2023, SHE:300725's revenue was 1.73 billion, an increase of 8.18% compared to the previous year's 1.59 billion. Earnings were 197.36 million, a decrease of -37.19%.